[1]
M. Rezaei-Tavirani, M. Zamanian-Azodi, F. Azizi-Jalilian, and S. Khodakarim, “Biomarker Profiling (Erbb2, P53, and PR) for Stage I of Breast Cancer”, Arch Adv Biosci, vol. 4, no. 4, Aug. 2013.